Study Conduct

Prometheus gets NIH grant for biomedical and behavioral research

Monday, October 5, 2015

Prometheus Research has been awarded more than $250,000 from the NIH to transform the way electronic data capture (EDC) forms are configured, integrated and shared for biomedical and behavioral health research. The grant, part of NIH’s Small Business Innovation Research (SBIR) program, seeks to empower mental health researchers to easily share, reuse and locate electronic data capture forms across a variety of EDC platforms.

[Read More]

Symbiodx, Cure Forward partner on precision medicine

Wednesday, September 30, 2015

Symbiodx, a molecular reference laboratory in the Pacific Northwest, and Cure Forward, a Cambridge, Mass.-based, multisided technology platform to support patient engagement, are collaborating to advance precision medicine. The partnership will provide patients with streamlined access to their genomic data and greater exposure to relevant clinical trials.

[Read More]

WCG, PCCTC partner to improve oncology research reviews

Tuesday, September 29, 2015

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, and the Prostate Cancer Clinical Trials Consortium (PCCTC), a multicenter clinical research organization specializing in cutting-edge prostate cancer research, have formed a new partnership to enhance the quality and efficiency of the consortium’s research review process.

[Read More]

NIH awards funding for junior faculty training

Friday, September 25, 2015

To encourage junior faculty at African academic institutions to pursue research careers, the NIH is awarding up to $36.5 million over five years in the next phase of the Medical Education Partnership Initiative (MEPI). Sub-Saharan Africa bears almost a quarter of the global disease burden, yet has only 3% of the world’s health workforce, according to the World Health Organization.

[Read More]

DREAM Challenge winners announced

Wednesday, September 23, 2015

Winners have been announced for the Prostate Cancer DREAM Challenge, the first research challenge in prostate cancer to marry crowdsourcing with data sharing, paving a new way to tackle key research questions about metastatic castration-resistant prostate cancer (mCRPC), an advanced form of the disease with poor outcomes.

[Read More]

Robert Califf seen as clinical research insider

Monday, September 21, 2015

Robert Califf, M.D., President Barack Obama’s nominee to be the next FDA commissioner and seen by some as a clinical research insider, is being called “a terrific choice” who is “very open to new ideas” by experts in the clinical trials sector.

[Read More]

Study: Mobile healthcare app use surging

Friday, September 18, 2015

The number of mobile health applications available to consumers now surpasses 165,000, as developers incorporate innovative data collection features linked to sensors and wearables, according to a new report released by the IMS Institute for Healthcare Informatics. While most available apps focus on overall wellness, healthcare systems and professionals are expressing greater interest and excitement in broader app use as barriers to mainstream adoption of mHealth are removed—especially in the area of chronic disease management.

[Read More]

Optimal Strategix Group launches study matching app

Wednesday, September 16, 2015

Optimal Strategix Group (OSG), based in Newtown, Pa., has launched its CAVII app, available for download in the Apple App Store. CAVII is an iOS-based clinical study matching and analytics platform. Ushering in a new era of patient engagement, CAVII’s aim is to revolutionize clinical studies through the use of analytics for superior patient matching. Through CAVII, clinical studies could become more cost-effective, efficient and ultimately more engaging and insightful for patients and clinicians.

[Read More]

Advisory boards amplify patients’ voices

Tuesday, September 15, 2015

A strong and growing desire to solicit feedback directly from patients, ex­perienced participants and their sup­port network is prompting many sponsors and CROs to assess, plan and implement patient advisory panels.

[Read More]